​

RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?

OverviewForecastFinancialsChart

RAPT Therapeutics Ownership Summary

RAPT Therapeutics is owned by 293.81% institutional investors, 0.49% insiders. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 57.45% of RAPT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.73% of its assets in RAPT Therapeutics shares.

RAPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRAPT Therapeutics293.81%0.49%-194.30%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Medicxi ventures management (jersey)22.35M57.45%$35.32M
Tcg crossover management13.14M33.76%$19.75M
Orbimed advisors13.14M33.76%$20.75M
Foresite capital management vi12.50M32.13%$19.75M
Bvf inc/il9.24M23.74%$14.60M
Redmile group6.48M16.64%$10.23M
Deep track capital, lp6.01M15.45%$9.50M
Perceptive advisors5.88M15.11%$9.29M
Fmr5.23M13.45%$8.27M
Vanguard group2.94M7.56%$4.65M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Foresite capital management vi12.50M8.80%$19.75M
Medicxi ventures management (jersey)22.35M6.68%$35.32M
Column group1.33M3.77%$2.10M
Tcg crossover management13.14M1.93%$19.75M
Redmile group6.48M0.71%$10.23M
Bvf inc/il9.24M0.49%$14.60M
Orbimed advisors13.14M0.43%$20.75M
Adar1 capital management1.17M0.37%$1.86M
Deep track capital, lp6.01M0.35%$9.50M
Ghost tree capital300.00K0.29%$915.00K

Top Buyers

HolderShares% AssetsChange
Medicxi ventures management (jersey)22.35M6.68%22.35M
Tcg crossover management13.14M1.93%13.14M
Orbimed advisors13.14M0.43%13.14M
Foresite capital management vi12.50M8.80%12.50M
Bvf inc/il9.24M0.49%9.24M

Top Sellers

HolderShares% AssetsChange
Column group1.33M3.77%-1.35M
Kingdon capital management575.00K0.13%-1.15M
Morgan stanley1.18M0.00%-726.44K
Alphabet---540.27K
Point72 asset management---525.22K

New Positions

HolderShares% AssetsChangeValue
Medicxi ventures management (jersey)22.35M6.68%22.35M$35.32M
Orbimed advisors13.14M0.43%13.14M$20.75M
Tcg crossover management13.14M1.93%13.14M$19.75M
Foresite capital management vi12.50M8.80%12.50M$19.75M
Bvf inc/il9.24M0.49%9.24M$14.60M

Sold Out

HolderChange
Farther finance advisors-2.00
Quest partners-5.00
Nelson, van denburg & campbell wealth management group-7.00
Us bancorp \de\-11.00
Gamma investing-27.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202490-5.26%114,301,746283.56%2935.01%5750.00%20-25.93%
Sep 30, 202495-18.10%29,799,990-6.32%761.13%38-32.14%27-18.18%
Jun 30, 2024116-17.14%31,809,166-0.17%821.20%56-25.33%3310.00%
Mar 31, 202414019.66%31,861,728-8.92%831.00%7519.05%30-14.29%
Dec 31, 202311715.84%34,982,1260.63%911.11%6350.00%35-7.89%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O2.00M5.73%-
Fidelity Growth Compy Commingled Pl S2.05M1.56%21.11K
Fidelity Growth Company Fund1.49M1.13%-18.17K
Vanguard US Total Market Shares ETF1.12M0.85%-
Vanguard Total Stock Mkt Idx Inv1.05M0.79%-
iShares Biotechnology ETF201.44K0.58%-
iShares Russell 2000 ETF744.95K0.56%-6.43K
Fidelity Growth Company K6481.38K0.36%-2.94K
Federated Hermes MDT Small Cap Core IS461.23K0.35%-
Federated Hermes MDT SCC Institutional461.23K0.35%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 05, 2024Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICERSell$20.46K
Dec 21, 2023HO WILLIAM Chief Medical OfficerSell$54.20K
Nov 28, 2023HO WILLIAM Chief Medical OfficerSell$20.58K
Oct 03, 2023HO WILLIAM Chief Medical OfficerSell$39.42K
Aug 18, 2023HO WILLIAM Chief Medical OfficerSell$47.30K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q2--
2024 Q1-1
2023 Q4-3
2023 Q3-1

RAPT Ownership FAQ

Who Owns RAPT Therapeutics?

RAPT Therapeutics shareholders are primarily institutional investors at 293.81%, followed by 0.49% insiders and -194.30% retail investors. The average institutional ownership in RAPT Therapeutics's industry, Biotech Stocks , is 68.48%, which RAPT Therapeutics exceeds.

Who owns the most shares of RAPT Therapeutics?

RAPT Therapeutics’s largest shareholders are Medicxi ventures management (jersey) (22.35M shares, 57.45%), Tcg crossover management (13.14M shares, 33.76%), and Orbimed advisors (13.14M shares, 33.76%). Together, they hold 124.98% of RAPT Therapeutics’s total shares outstanding.

Does Blackrock own RAPT Therapeutics?

BlackRock is not among the top 10 institutional shareholders of RAPT Therapeutics.

Who is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested?

Foresite capital management vi is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.80% of its assets in 12.5M RAPT Therapeutics shares, valued at 19.75M$.

Who is the top mutual fund holder of RAPT Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of RAPT Therapeutics shares, with 5.73% of its total shares outstanding invested in 2M RAPT Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools